Skip to main content

Your search for “Liver” returned 282 results

New Congenital Heart Disease Program Treats Patients with Complex Cardiac Needs

February 11, 2019

The Adult Congenital Heart Disease Program at UC San Diego Health is the only one in the region to provide a multi-disciplinary team with extensive knowledge in congenital heart disease and help patients transition from pediatric care to adult care.

Harnessing Cancer’s Methylation Footprint for More Precise Diagnosis and Prognosis

June 27, 2017

In a new study, researchers at University of California San Diego School of Medicine, with colleagues in Xijing Hospital and Sun Yat-sen Cancer Center in China, report that DNA methylation can provide effective markers for at least four major cancers, not only correctly differentiating malignant tissues from normal, but also…

Promising Clinical Trial Results for Drug for Rare Disease in Which Patients Can’t Eat Fat

August 7, 2019

In a Phase III clinical trial, the drug volanesorsen significantly reduced blood fat (triglyceride) levels in participants with a rare disease called familial chylomicronemia syndrome; finding could also help inform better prevention methods and treatments for many types of heart disease.

Iron Buildup in Brain Linked to Higher Risk for Movement Disorders

August 1, 2022

UC San Diego researchers report that individuals with two copies of a gene mutation show evidence of substantial iron buildup in regions of the brain, raising risk for movement disorders like Parkinson’s disease.

Knocking Out Key Protein in Mice Boosts Insulin Sensitivity

November 10, 2011

By knocking out a key regulatory protein, scientists at the University of California, San Diego School of Medicine and the Ecole Polytechnique Federale de Lausanne (EPFL) in Switzerland dramatically boosted insulin sensitivity in lab mice, an achievement that opens a new door for drug development and the treatment of diabetes.

Nanosponges Soak Up Toxins Released by Bacterial Infections and Venom

April 14, 2013

Engineers at the University of California, San Diego have invented a “nanosponge” capable of safely removing a broad class of dangerous toxins from the bloodstream – including toxins produced by MRSA, E. coli, poisonous snakes and bees.

Half a Million Tests and Many Mosquitoes Later, New Buzz about a Malaria Prevention Drug

December 6, 2018

Researchers spent two years testing chemical compounds for their ability to inhibit the malaria parasite at an earlier stage in its lifecycle than most current drugs, revealing a new set of chemical starting points for the first drugs to prevent malaria instead of just treating the symptoms.

New Blood Test Could Help Detect and Locate Cancer Early On

March 6, 2017

Bioengineers at the University of California San Diego have developed a new blood test that could detect cancer — and locate where in the body the tumor is growing. The study could provide a way to diagnose cancer early on without having to do invasive surgical procedures like biopsies.

“Molecular Rosetta Stone” Reveals How our Microbiome Talks to Us

March 11, 2024

Researchers from Skaggs School of Pharmacy and Pharmaceutical Science at the University of California San Diego have uncovered thousands of previously unknown bile acids, a type of molecule used by our gut microbiome to communicate with the rest of the body.

How to Reset a Diseased Cell

May 1, 2015

In proof-of-concept experiments, researchers at University of California, San Diego School of Medicine demonstrate the ability to tune medically relevant cell behaviors by manipulating a key hub in cell communication networks. The manipulation of this communication node, reported in this week’s issue of Proceedings of the National Academy of Sciences,…

Category navigation with Social links